Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the improve-it trial
Answers
Answered by
0
Answer:
Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial
Similar questions